New Types of Cytotoxic Colloids for Cancer Therapy

Arch Surg. 1961;83(6):890-893. doi:10.1001/archsurg.1961.01300180090017.
Text Size: A A A
Published online

Cytotoxic colloids such as radioactive gold and chromium phosphate have shown limited usefulness for clinical cancer therapy. In their favor is the fact that isotopes of suitable decay characteristics have been chosen to make their clinical use practical. Also, the transport characteristics of presently used colloids are relatively good. Thus, if radioactive gold or chromium phosphate is instilled into the peritoneal or pleural cavity, most of the colloid stays in the cavity where colloid is instilled.

The localization pattern of all colloids used to date, however, has seriously hampered their usefulness. Colloids, radioactive or not, share a common distribution in the body. They concentrate in normal tissue and in the normal portions of lymph nodes. Specifically, colloids are not taken up by tumor tissue or by that part of nodes replaced by tumor.1,2

For clinical usefulness in destroying cancer a localization pattern is needed which is the exact opposite


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.